All sponsors

CSPC Ouyi Pharmaceutical Co., Ltd. $1093.HK

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS10
PHASE 3 / 2-35
RECRUITING1
READOUTS ≤12 MONTHS5
Open CSPC Ouyi Pharmaceutical Co., Ltd. on the live radar map → 📅 $1093.HK readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
SYHX2011
NCT06354114
P2Not yet recruitingAdvanced Breast Cancer802024-10-31
Dextromethorphan and Bupropion Sustained-Release Tablets
NCT06958692
P3RecruitingMajor Depressive Disorder (MDD)3882026-09-30
NCT07026968
NCT07026968
P3Active, not recruitingType 2 Diabetes8152026-10-30
SYHX1901
NCT06943950
P3Not yet recruitingModerate to Severe Plaque Psoriasis5002027-04-28
SYHX1901
NCT06562894
P2Not yet recruitingSevere Alopecia Areata1562027-05-31 (+17 mo)
Bempedoic Acid Tablet
NCT07623915
P3Not yet recruitingPrimary Hyperlipidemia2222027-06-30
SYH2069 Injection (group 1)
NCT07796477
P2Not yet recruitingT2DM (Type 2 Diabetes Mellitus)2402027-09-28
SYH2069 Injection
NCT07803991
P2Not yet recruitingOverweight or Obesity3602027-09-30
SYH2066
NCT07881991
P2Not yet recruitingRespiratory Syncytial Virus Infections802027-12-31
Liposomal Irinotecan
NCT06571461
P3Not yet recruitingPancreatic Cancer4082028-01